How well flu and COVID-19 vaccines protect people in underserved Arizona communities
RFA-IP-22-004, Platform to Assess Influenza and COVID-19 Vaccine Effectiveness in Underserved Arizona Populations
['FUNDING_U01'] · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · NIH-11140260
This project looks at how well flu and COVID-19 vaccines protect people who get care in diverse, underserved areas of Phoenix, including people living with HIV.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS (nih funded) |
| Locations | 1 site (SCOTTSDALE, UNITED STATES) |
| Trial ID | NIH-11140260 on ClinicalTrials.gov |
What this research studies
From a patient's view, researchers will follow people who attend participating outpatient clinics to see who gets flu or COVID-19 and whether vaccination prevents sickness and hospital visits. They will combine medical records, symptom reports, and laboratory testing to identify infections and outcomes over time. The work focuses on a diverse and socioeconomically varied Phoenix population and includes people with weakened immune systems such as those with HIV. Data will help compare protection from seasonal flu vaccines, COVID-19 vaccines, and boosters during overlapping respiratory virus seasons.
Who could benefit from this research
Good fit: Ideal candidates are people who receive outpatient care at participating clinics in Phoenix/Maricopa County, especially those from underserved communities or with conditions like HIV that affect immune response.
Not a fit: People who live outside the Phoenix area or do not receive care at the participating clinics are unlikely to be enrolled or directly benefit from this project.
Why it matters
Potential benefit: If successful, this work could help tailor vaccine and booster recommendations for diverse and underserved Arizona communities to reduce infections and severe illness.
How similar studies have performed: Previous observational studies have measured flu or COVID-19 vaccine effectiveness separately, but combining both in a diverse, underserved Arizona population is relatively new.
Where this research is happening
SCOTTSDALE, UNITED STATES
- ARIZONA STATE UNIVERSITY-TEMPE CAMPUS — SCOTTSDALE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MURUGAN, VEL — ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
- Study coordinator: MURUGAN, VEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.